Results 111 to 120 of about 610,538 (183)

A Structural Insight Into Two Important ErbB Receptors (EGFR and HER2) and Their Relevance to Non-Small Cell Lung Cancer. [PDF]

Arch Pharm (Weinheim)
Topalan E, Büyükgüngör A, Çiğdem M, Güra S, Sever B, Otsuka M, Fujita M, Demirci H, Ciftci H.   +8 more
europepmc   +1 more source

Natural Products as Chemopreventive Agents by Potential Inhibition of the Kinase Domain in ErbB Receptors. [PDF]

Molecules, 2017
Olivero-Acosta M, Maldonado-Rojas W, Olivero-Verbel J.   +2 more
europepmc   +1 more source

ErbB receptors and tetraspanins: Casting the net wider [PDF]

The International Journal of Biochemistry & Cell Biology, 2016
Fedor, Berditchevski, Elena, Odintsova
openaire   +2 more sources

Dacomitinib, a pan-inhibitor of ErbB receptors, suppresses growth and invasive capacity of chemoresistant ovarian carcinoma cells. [PDF]

Sci Rep, 2017
Momeny M, Zarrinrad G, Moghaddaskho F, Poursheikhani A, Sankanian G, Zaghal A, Mirshahvaladi S, Esmaeili F, Eyvani H, Barghi F, Sabourinejad Z, Alishahi Z, Yousefi H, Ghasemi R, Dardaei L, Bashash D, Chahardouli B, Dehpour AR, Tavakkoly-Bazzaz J, Alimoghaddam K, Ghavamzadeh A, Ghaffari SH.   +21 more
europepmc   +1 more source

Ubiquitination and deubiquitination of ERBB receptors

, 2014
Radboud Universiteit Nijmegen, 24 januari ...
openaire   +1 more source

The spatiotemporal organization of ErbB receptors: insights from microscopy. [PDF]

Cold Spring Harb Perspect Biol, 2014
Valley CC, Lidke KA, Lidke DS.
europepmc   +1 more source

ErbB-receptors in antiestrogen resistance [PDF]

Breast Cancer Research, 2000
openaire   +1 more source

ErbB Receptor Family Protein [PDF]

, 2020
openaire   +1 more source

Coronary Microvascular Dysfunction: Epidemiology, Pathophysiology, Diagnosis, and Treatment. [PDF]

MedComm (2020)
Ge Z, Zhang M, Ning X, Du Y, Su L, Wu X, Zhang J, Liu T, Wang X.   +8 more
europepmc   +1 more source

Neuregulin-1 as a Context-Dependent Regulator of Neuroinflammation and Neural Repair: Mechanisms, Disease Relevance, and Therapeutic Challenges. [PDF]

Cells
Ford GD, McGinley C, Oyolola O, Adeyemi O, Surles-Zeigler MC, Rahimpour S, Ford BD.   +6 more
europepmc   +1 more source